GB607839A
(en)
|
1946-02-12 |
1948-09-06 |
Bristol Aeroplane Co Ltd |
Improvements in or relating to gas-turbine power-plants
|
EP0227241B1
(en)
|
1985-10-17 |
1996-09-11 |
Zeneca Inc. |
Medicinal indole and indazole keto sulphone derivatives
|
US5744101A
(en)
*
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US5143854A
(en)
*
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
CA2081507C
(en)
|
1991-10-30 |
2004-04-06 |
Shun-Ichi Murahashi |
Process for producing epoxide
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
AU677776B2
(en)
|
1992-04-02 |
1997-05-08 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
US5569450A
(en)
|
1993-03-17 |
1996-10-29 |
Minnesota Mining And Manufacturing Company |
Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
|
DE69529101T2
(de)
|
1994-06-15 |
2003-11-13 |
Wellcome Found |
Zwischenprodukte verwendbar in der Herstellung von Enzym-Inhibitoren
|
US6124334A
(en)
|
1995-02-03 |
2000-09-26 |
Pharmacia & Upjohn Company |
Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
|
TR199701167T1
(xx)
|
1995-04-14 |
1998-03-21 |
Glaxo Wellcome Inc. |
Albuterol i�in �l��lm�� doz inhaleri.
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
US6245804B1
(en)
|
1997-05-30 |
2001-06-12 |
Schering Aktiengesellschaft |
Nonsteroidal gestagens
|
TW533865U
(en)
|
1997-06-10 |
2003-05-21 |
Glaxo Group Ltd |
Dispenser for dispensing medicament and actuation indicating device
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
DE69918422T2
(de)
|
1998-03-14 |
2005-08-11 |
Altana Pharma Ag |
Phthalazinone als PDE3/4 Inhibitoren
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
DE19856475A1
(de)
|
1998-11-27 |
2000-05-31 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
US6390291B1
(en)
|
1998-12-18 |
2002-05-21 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6119853A
(en)
|
1998-12-18 |
2000-09-19 |
Glaxo Wellcome Inc. |
Method and package for storing a pressurized container containing a drug
|
US6315112B1
(en)
|
1998-12-18 |
2001-11-13 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
US6352152B1
(en)
|
1998-12-18 |
2002-03-05 |
Smithkline Beecham Corporation |
Method and package for storing a pressurized container containing a drug
|
CN1353717A
(zh)
|
1999-05-04 |
2002-06-12 |
莱加制药公司 |
四环***受体调节剂化合物及其方法
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
DE10038639A1
(de)
*
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
IL154175A0
(en)
|
2000-08-05 |
2003-07-31 |
Glaxo Group Ltd |
17. beta.-carbothioate 17. alpha-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
|
AR035205A1
(es)
|
2000-09-29 |
2004-05-05 |
Glaxo Group Ltd |
Compuestos utiles en el tratamiento de enfermedades inflamatorias, proceso para su preparacion, intermediarios y composiciones farmaceuticas
|
WO2002057414A2
(en)
*
|
2000-10-20 |
2002-07-25 |
Expression Diagnostics, Inc. |
Leukocyte expression profiling
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE60220887T2
(de)
|
2001-03-08 |
2008-02-28 |
Glaxo Group Ltd., Greenford |
Agonisten von beta-adrenorezeptoren
|
WO2002076933A1
(en)
|
2001-03-22 |
2002-10-03 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
US20030148298A1
(en)
*
|
2001-04-03 |
2003-08-07 |
O''toole Margot |
Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
|
AU2002253342B2
(en)
|
2001-04-30 |
2007-01-04 |
Glaxo Group Limited |
Novel anti-inflammatory androstane derivatives
|
US7026121B1
(en)
*
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
ATE399174T1
(de)
|
2001-06-12 |
2008-07-15 |
Glaxo Group Ltd |
Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
|
CA2458534C
(en)
|
2001-09-14 |
2011-11-01 |
Glaxo Group Limited |
Phenethanolamine derivatives for treatment of respiratory diseases
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
AU2003202216A1
(en)
|
2002-01-14 |
2003-07-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
EP1467730A4
(en)
|
2002-01-22 |
2010-03-10 |
Univ California |
Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
DK1490062T3
(da)
|
2002-03-26 |
2008-04-28 |
Boehringer Ingelheim Pharma |
Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US6897224B2
(en)
|
2002-04-02 |
2005-05-24 |
Schering Ag |
Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
WO2003086294A2
(en)
|
2002-04-11 |
2003-10-23 |
Merck & Co., Inc. |
1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
ATE381535T1
(de)
|
2002-04-25 |
2008-01-15 |
Glaxo Group Ltd |
Phenethanolaminderivate
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
EP1521733B1
(en)
|
2002-07-08 |
2014-08-20 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
PL375442A1
(en)
|
2002-07-18 |
2005-11-28 |
Bristol-Myers Squibb Company |
Modulators of the glucocorticoid receptor and method
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
US7118865B2
(en)
*
|
2002-08-16 |
2006-10-10 |
Regents Of The University Of Minnesota |
Methods for diagnosing severe systemic lupus erythematosus
|
US6858627B2
(en)
|
2002-08-21 |
2005-02-22 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2004024728A2
(en)
|
2002-09-16 |
2004-03-25 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
|
GB0230045D0
(en)
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
JP4520309B2
(ja)
|
2002-09-20 |
2010-08-04 |
メルク・シャープ・エンド・ドーム・コーポレイション |
選択的糖質コルチコイド受容体調節剤としてのオクタヒドロ−2−H−ナフト[1,2−f]インドール−4−カルボキサミド誘導体
|
GB0224084D0
(en)
|
2002-10-16 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
WO2004037807A2
(en)
|
2002-10-22 |
2004-05-06 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
PT1556342E
(pt)
|
2002-10-28 |
2008-04-28 |
Glaxo Group Ltd |
Derivado de fenetanolamina para o tratamento de doenças respiratórias
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
CA2504144A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis of immune related diseases using pro7
|
WO2004063163A1
(en)
|
2003-01-03 |
2004-07-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
US20040191818A1
(en)
*
|
2003-02-26 |
2004-09-30 |
O'toole Margot Mary |
Compositions and methods for diagnosing and treating autoimmune diseases
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
BRPI0412231A
(pt)
|
2003-07-01 |
2006-08-22 |
Schering Ag |
derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação
|
US20050090559A1
(en)
*
|
2003-07-01 |
2005-04-28 |
Markus Berger |
Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
UY28526A1
(es)
*
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
PT1670458E
(pt)
|
2003-10-08 |
2007-03-30 |
Schering Ag |
Derivados de tetra-hidronaftaleno, processo para a sua preparação e utilização como inibidor de inflamação
|
DE10347385A1
(de)
|
2003-10-08 |
2005-05-12 |
Schering Ag |
Umgelagerte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
US7662821B2
(en)
|
2003-10-08 |
2010-02-16 |
Bayer Schering Pharma Ag |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
US7638515B2
(en)
|
2003-10-08 |
2009-12-29 |
Bayer Schering Pharma Aktiengesellschaft |
Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
WO2005037811A1
(de)
|
2003-10-08 |
2005-04-28 |
Dsm Fine Chemicals Austria Nfg Gmbh & Co. Kg |
Verfahren zur herstellung chiraler substituierter epoxide
|
TW200811172A
(en)
|
2003-10-14 |
2008-03-01 |
Glaxo Group Ltd |
Muscarinic acetylcholine receptor antagonists
|
WO2005040145A1
(en)
|
2003-10-16 |
2005-05-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
PL1699512T3
(pl)
|
2003-11-03 |
2012-11-30 |
Glaxo Group Ltd |
Urządzenie do dozowania płynów
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
CA2557004A1
(en)
|
2003-12-19 |
2005-06-30 |
Glaxo Group Limited |
Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors
|
WO2005090352A1
(en)
|
2004-03-16 |
2005-09-29 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
GB0405937D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
JP2007530541A
(ja)
|
2004-03-22 |
2007-11-01 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックスとしてのα−トリフルオロメチルアルコール又はアミン
|
US7256300B2
(en)
|
2004-03-30 |
2007-08-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
US20050222154A1
(en)
|
2004-04-05 |
2005-10-06 |
Hartmut Rehwinkel |
Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
WO2006000401A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
Substituted oxazines as glucocorticoid receptor modulators
|
WO2006000398A1
(en)
|
2004-06-28 |
2006-01-05 |
Glaxo Group Limited |
2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators
|
GB0418045D0
(en)
|
2004-08-12 |
2004-09-15 |
Glaxo Group Ltd |
Compounds
|
US7571055B2
(en)
*
|
2004-10-13 |
2009-08-04 |
Regents Of The University Of Minnesota |
Systemic lupus erythematosus
|
CA2584318A1
(en)
|
2004-10-19 |
2006-05-04 |
F. Hoffmann-La Roche Ag |
Quinoline derivatives
|
US20090124588A1
(en)
|
2005-01-10 |
2009-05-14 |
Glaxo Group Limited |
Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
|
ATE517908T1
(de)
|
2005-01-10 |
2011-08-15 |
Glaxo Group Ltd |
Androstan-17-alpha-carbonat-derivate zur verwendung bei der behandlung allergischer und entzündlicher zustände
|
JP2008535884A
(ja)
*
|
2005-04-14 |
2008-09-04 |
グラクソ グループ リミテッド |
グルココルチコイド受容体リガンドとしてのインダゾール
|
GB0620406D0
(en)
*
|
2006-10-13 |
2006-11-22 |
Glaxo Group Ltd |
Novel compounds
|